Task: Answer the multiple-choice question.
Question: Which drug exhibits a 18.707% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCOc1ccc(-c2nnc(SCC(=O)N3CCNC3=O)o2)cc1
b.) Cc1ccccc1-n1ccnc1SCC(=O)NCC1CCCO1
c.) CCOc1ccc(-n2c(C)nc3cc(C(=O)NCc4ccc5c(c4)OCO5)ccc32)cc1
Answer: a. CCOc1ccc(-c2nnc(SCC(=O)N3CCNC3=O)o2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(-c2nnc(SCC(=O)N3CCNC3=O)o2)cc1
CCOc1ccc(-c2nnc(SCC(=O)N3CCNC3=O)o2)cc1
1-[2-[[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetyl]imidazolidin-2-one